Get a glimpse into our company and investor data—powered by the PitchBook Platform
A drug development and marketing right in Japan. The drug development right is associated to treat cardiovascular indications and genetic disease phenylketonuria (PKU).
This information is reserved for PitchBook Platform users. To explore Daiichi Suntory Pharma (Rights To 6R-BH4)‘s full profile, request access.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.